Increased Fibrinolysis as a Specific Marker of Poor Outcome After Cardiac Arrest

被引:14
|
作者
Buchtele, Nina [1 ]
Schoergenhofer, Christian [1 ]
Spiel, Alexander O. [2 ]
Jilma, Bernd [1 ]
Schwameis, Michael [2 ]
机构
[1] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria
[2] Med Univ Vienna, Dept Emergency Med, Vienna, Austria
基金
奥地利科学基金会;
关键词
cardiac arrest; early prediction; fibrinolysis; point-of-care; thrombelastometry; outcome; DISSEMINATED INTRAVASCULAR COAGULATION; HUMAN-ENDOTHELIAL CELLS; SYMPATHOADRENAL ACTIVATION; D-DIMER; HYPERFIBRINOLYSIS; HYPOTHERMIA; MORTALITY; TRAUMA; THROMBOELASTOMETRY; THROMBELASTOMETRY;
D O I
10.1097/CCM.0000000000003352
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Recent data suggest that early increased fibrinolysis may be associated with unfavorable prognosis in cardiac arrest. The current study aimed to assess whether there is an optimal fibrinolysis cutoff value as determined by thrombelastometry at hospital admission to predict poor outcome in a cohort of adult patients with out-of-hospital cardiac arrest. Design: Prospective observational cohort study. Setting: Emergency department of a 2.100-bed tertiary care facility in Vienna, Austria, Europe. Patients: Patients with out-of-hospital cardiac arrest of presumed cardiac origin, subjected to targeted temperature management, who had achieved return of spontaneous circulation at admission were analyzed. Interventions: None. Measurements and Main Results: Fibrinolysis was assessed by thrombelastometry at the bedside immediately after hospital admission and is given as maximum lysis (%). The outcome measure was the optimal cutoff for maximum lysis at hospital admission to predict poor outcome (a composite of Cerebral Performance Category 3-5 or death) at day 30, assessed by receiver operating characteristic curve analysis. Seventy-eight patients (61% male, median 59 yr) were included in the study from March 2014 to March 2017. Forty-two patients (54%) had a poor 30-day outcome including 23 nonsurvivors (30%). The maximum lysis cutoff at admission predicting poor 30-day outcome with 100% specificity (95% CI, 90-100%) was greater than or equal to 20%. Tissue-type plasminogen activator antigen levels were likewise elevated in patients with poor neurologic outcome or death 52ng/mL (interquartile range, 26-79ng/mL) versus 29ng/mL (interquartile range, 17-49ng/mL; p = 0.036). Conclusions: Increased fibrinolysis at admission assessed by thrombelastometry specifically predicts poor outcome in cardiac arrest with presumed cardiac etiology.
引用
下载
收藏
页码:E995 / E1001
页数:7
相关论文
共 50 条
  • [21] Head computed tomographic measurement as an early predictor of poor outcome after cardiac arrest
    Knappe, M. Moseby
    Pellis, T.
    Dragancea, I.
    Friberg, H.
    Horn, J.
    Kuiper, M. A.
    Nielsen, N.
    Roncarati, A.
    Cronberg, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 88 - 89
  • [22] Predictive Modeling for Poor Neurologic Outcome After Cardiac Arrest Using Multimodal Approach
    Kim, J., Sr.
    Park, Y., Sr.
    ANNALS OF EMERGENCY MEDICINE, 2018, 72 (04) : S137 - S137
  • [23] PREDICTORS OF POOR NEUROLOGIC OUTCOME AFTER INDUCED MILD HYPOTHERMIA FOLLOWING CARDIAC ARREST
    Freeman, W. D.
    Barrett, K. M.
    Biewend, M. L.
    Johnson, M. M.
    Divertie, G. D.
    Meschia, J. F.
    NEUROLOGY, 2009, 73 (12) : 997 - 998
  • [24] Copeptin as a marker of outcome after cardiac arrest: a sub-study of the TTM trial
    Joachim Düring
    Martin Annborn
    Tobias Cronberg
    Josef Dankiewicz
    Yvan Devaux
    Christian Hassager
    Janneke Horn
    Jesper Kjaergaard
    Michael Kuiper
    Homa Rafi Nikoukhah
    Pascal Stammet
    Johan Undén
    Michael Jaeger Wanscher
    Matt Wise
    Hans Friberg
    Niklas Nielsen
    Critical Care, 24
  • [25] Heart rate complexity: An early prognostic marker of patient outcome after cardiac arrest
    Riganello, Francesco
    Zubler, Frederic
    Haenggi, Matthias
    De Lucia, Marzia
    CLINICAL NEUROPHYSIOLOGY, 2022, 134 : 27 - 33
  • [26] Copeptin as a marker of outcome after cardiac arrest: a sub-study of the TTM trial
    During, Joachim
    Annborn, Martin
    Cronberg, Tobias
    Dankiewicz, Josef
    Devaux, Yvan
    Hassager, Christian
    Horn, Janneke
    Kjaergaard, Jesper
    Kuiper, Michael
    Nikoukhah, Homa Rafi
    Stammet, Pascal
    Unden, Johan
    Wanscher, Michael Jaeger
    Wise, Matt
    Friberg, Hans
    Nielsen, Niklas
    CRITICAL CARE, 2020, 24 (01):
  • [27] Epinephrine and outcome after cardiac arrest
    Fromm, RE
    ANNALS OF INTERNAL MEDICINE, 1999, 130 (11) : 942 - 942
  • [28] Optimizing outcome after cardiac arrest
    Nolan, Jerry P.
    CURRENT OPINION IN CRITICAL CARE, 2011, 17 (05) : 520 - 526
  • [29] Outcome and prognostication after cardiac arrest
    Henson, Theresa
    Rawaduzy, Cameron
    Salazar, Marco
    Sebastian, Adonai
    Weber, Harli
    Al-Mufti, Fawaz
    Mayer, Stephan A.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2022, 1508 (01) : 23 - 34
  • [30] Increased serum creatinine: A marker for adverse outcome before and after cardiac surgery
    Simmons, PI
    Anderson, RJ
    CRITICAL CARE MEDICINE, 2002, 30 (07) : 1664 - 1665